A Randomized, Controlled Study of the Safety and Efficacy of Squalamine Lactate Eye Drops in Combination With Ranibizumab in Patients With Diabetic Macular Edema.
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 03 Jun 2016
At a glance
- Drugs Squalamine (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 29 Sep 2015 Status changed from not yet recruiting to withdrawn prior to enrolment as per ClinicalTrials.gov record.
- 10 Apr 2014 New trial record